Efficient treatments reduce the cost-efficiency of breast cancer screening

Annals of Internal Medicine

Volumn 164, Issue 4, 2016, Pages 297-298

  Autier, Philippe ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BREAST CANCER; BREAST DENSITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER THERAPY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; ECHOGRAPHY; EDITORIAL; HUMAN; MAMMOGRAPHY; META ANALYSIS (TOPIC); MORTALITY RATE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; THERAPY EFFECT; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; FEMALE; MASS SCREENING; MORTALITY;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING;

EID: 84958745747     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-2789     Document Type: Editorial

References (10)

1. Birnbaum J, Gadi VK, Markowitz E, Etzioni R. The effect of treatment advances on the mortality results of breast cancer screening trials: a microsimulation model. Ann Intern Med. 2016;164:236-43. doi:10.7326/M15-0754
2. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380:1778-86. [PMID: 23117178] doi:10.1016/S0140-6736(12)61611-0
3. Friedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014;311:2499-507. [PMID: 25058084] doi:10.1001/jama.2014.6095
4. Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, et al; J-START investigator groups. Sensitivity and specificity of mam-mography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet. 2015. [PMID: 26547101] doi:10.1016/S0140-6736(15)00774-6
5. Lin D, Moy L, Axelrod D, Smith J. Utilization of magnetic resonance imaging in breast cancer screening. Curr Oncol. 2015;22: e332-5. [PMID: 26628872] doi:10.3747/co.22.2882
6. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;6:CD001877. [PMID: 23737396] doi:10.1002/14651858.CD001877.pub5
7. Morrison AS. Intermediate determinants of mortality in the evaluation of screening. Int J Epidemiol. 1991;20:642-50. [PMID: 1955248]
8. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 1995;75:2507-17. [PMID: 7736395]
9. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L; Trial Management Group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368:2053-60. [PMID: 17161727]
10. Autier P, Boniol M, Smans M, Sullivan R, Boyle P. Statistical anal yses in Swedish randomised trials on mammography screening and in other randomised trials on cancer screening: a systematic review. J R Soc Med. 2015;108:440-50. [PMID: 26152677] doi:10.1177/0141076815593403